---
$id: https://graph.org.ai/products/commodity/51384515
$type: Product
source: UNSPSC
code: "51384515"
title: "Oxaprozin"
class: "51384500"
classTitle: "Nonsteroidal anti inflammatory propionates"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxaprozin

**UNSPSC Code**: 51384515
**Class**: [Nonsteroidal anti inflammatory propionates](Nonsteroidal anti inflammatory propionates.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MHJ80W9LRB, chemically known as 4,5-diphenyl-2-oxazolepropionic acid but generally known as oxaprozin, which bears US NIH Compound Identifier 4614. European Medicines Agency schedules Oxaprozin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09502MIG. The term OXAPROZIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules oxaprozin in its Anatomical Therapeutic Chemical (ATC) Classification. OXAPROZIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxaprozin under HS 29349990 and SITC 51579. As of Q4 2014, OXAPROZIN remains the US FDA Preferred Term for this commodity. Oxaprozin bears US NLM identifiers UMLS ID C0603695 and NCI Concept Code C29307. SMILES: O1C(C(NC1CCC(=O)O)C1CCCCC1)C1CCCCC1.

